Useful Despite Limited Evidence
Clinicians use these tests despite evidence gaps
Sep 17, 2026 · 16 min · 9 segments
In this episode, we discuss viscoelastic testing in ICU using ROTEM. We cover the main assays (EXTEM, INTEM, FIBTEM, APTEM and HEPTEM), the key parameters (CT, CFT, A10, MCF and ML), and the expected…
So I guess today's snippet is about viscoelastic assays that we use in ICU for testing the coagulation pathways.
So Maddy, the question is with regards to viscoelastic assays, can you please describe the expected alterations and underlying mechanisms resulting from the following? A, platelet dysfunction.
And you can use either Teg or Rotem in your answer as a test that we choose to test these different settings.
Yeah, so I'm going to speak about Rotem because in the institutions that I've worked at, that's the main viscoelastic test that's used, but I know some other places do use Teg.
I thought we'd first just talk a little bit about the different tests with the main, I guess, cartridges that are used for Rotem, just with a quick overview.
So the main ones that we generally see are XTEM, INTEM, FIBTEM, APTEM and HEPTEM.
And there are some other ones which I won't go into today.
But XTEM basically contains tissue factors.
So this tests the extrinsic pathway of coagulation.
It's similar to the prothrombin type.
The INTEM contains phospholipidic acid and it tests the intrinsic pathway.
The FIV-TEM contains something called cytocalicin D, which is a platelet inhibitor.
So this blocks the platelets contribution to clot formation.
So this assesses fibridogen function and it's used in conjunction with the X-TEM.
And the APS-TEM is the same as the X-TEM, except it also contains aprotitin, which inhibits fibrinolysis.
So therefore, when you compare XTEM to APTEM, it allows for the detection of hyperfibrinolysis.
And finally, HEPTEM uses the same cartridge or same test of the INTEM, except it also contains heparinase.
This is particularly important, say, if it's a patient who is on bypass or post-bypass where they have quite a big effect of heparin, which
might be impacting on their coagulation status.
So I guess today's snippet is about viscoelastic assays that we use in ICU for testing the coagulation pathways.
So Maddy, the question is with regards to viscoelastic assays, can you please describe the expected alterations and underlying mechanisms resulting from the following? A, platelet dysfunction.
And you can use either Teg or Rotem in your answer as a test that we choose to test these different settings.
Yeah, so I'm going to speak about Rotem because in the institutions that I've worked at, that's the main viscoelastic test that's used, but I know some other places do use Teg.
I thought we'd first just talk a little bit about the different tests with the main, I guess, cartridges that are used for Rotem, just with a quick overview.
So the main ones that we generally see are XTEM, INTEM, FIBTEM, APTEM and HEPTEM.
And there are some other ones which I won't go into today.
But XTEM basically contains tissue factors.
So this tests the extrinsic pathway of coagulation.
It's similar to the prothrombin type.
The INTEM contains phospholipidic acid and it tests the intrinsic pathway.
The FIV-TEM contains something called cytocalicin D, which is a platelet inhibitor.
So this blocks the platelets contribution to clot formation.
So this assesses fibridogen function and it's used in conjunction with the X-TEM.
And the APS-TEM is the same as the X-TEM, except it also contains aprotitin, which inhibits fibrinolysis.
So therefore, when you compare XTEM to APTEM, it allows for the detection of hyperfibrinolysis.
And finally, HEPTEM uses the same cartridge or same test of the INTEM, except it also contains heparinase.
This is particularly important, say, if it's a patient who is on bypass or post-bypass where they have quite a big effect of heparin, which
might be impacting on their coagulation status.
Every episode on Radar is fully transcribed, speaker-labeled, and rich with metadata. Here is a taste of this one. Try Radar for free to see the rest.
3 of 5
Useful Despite Limited Evidence
Clinicians use these tests despite evidence gaps
The Hyperfibrinolysis Signature
One graph can expose dangerous clot breakdown
Smarter Blood Product Decisions
Testing can make transfusion decisions more precise
+2 more clips · 5 min 20 sec of audio in all
7 of 17
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
All 5 clips — the highlight moments, each cut as its own audio, with a title and a speaker
All 9 segments — the transcript broken into labeled sections, every ad read marked
All 17 topics — jump to every other episode discussing the same subject
Every related episode — other shows Radar links to this one
No account is needed to search Radar.